This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

By Manfred Sakel, M.D. Price, $5. Pp. 363, with no illustrations. Philosophical Library, Inc., 15 E. 40th St., New York 16, 1958.

Charles Shagass, Reviewer

AMA Arch Intern Med. 1959;104(1):162-163.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Manfred Sakel introduced insulin shock therapy in 1927, only two years after his graduation from medical school. He began his work with drug addicts and quickly extended the therapy to schizophrenics. When he reported that this most refractory of psychoses was favorably influenced by insulin therapy, he was greeted with skepticism and opposition. However, Poetzl, Director of the Vienna Psychiatric Clinic, took Sakel under his wing and gave him the clinical facilities to develop his method of treatment. In relatively few years insulin shock therapy was accepted all over the world as the treatment of choice for schizophrenia. It furnished the impetus for the introduction of Metrazol and electric convulsive therapies for mental disorder It may also be given credit for facilitating the current upsurge of interest and activity in pharmacotherapy and biochemical concepts of psychosis.

In view of the tremendously important psychiatric developments which he initiated, Sakel's place as . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?